Disposals:
Amgen, Inc. (NASDAQ:AMGN) EVP Sean E. Harper sold 1,525 shares of the firm’s stock in a transaction that occurred on Monday, July 16th. The stock was sold at an average price of $195.71, for a total transaction of $298,457.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through the
SEC website.
Sean E. Harper also recently made the following trade(s):
-On Tuesday, June 12th, Sean E. Harper sold 1,525 shares of Amgen stock. The shares were sold at an average price of $184.27, for a total transaction of $281,011.75.
-On Monday, May 14th, Sean E. Harper sold 1,525 shares of Amgen stock. The shares were sold at an average price of $174.10, for a total transaction of $265,502.50.
Shares of Amgen opened at $194.88 on Tuesday, MarketBeat.com reports. Amgen, Inc. has a 52-week low of $163.31 and a 52-week high of $201.23. The company has a market capitalization of $129.63 billion, a price-to-earnings ratio of 15.19, a price-to-earnings-growth ratio of 2.43 and a beta of 1.38. The company has a current ratio of 3.88, a quick ratio of 3.60 and a debt-to-equity ratio of 2.14.
Read more …
Delta Air Lines, Inc. (NYSE:DAL) COO W Gilbert West sold
10,000 shares of the stock in a transaction that occurred on Wednesday, July
18th. The shares were sold at an average price of $52.65, for a total
transaction of $526,500.00. Following the sale, the chief operating officer now
directly owns 95,447 shares of the company’s stock, valued at approximately
$5,025,284.55. The transaction was disclosed in a filing with the SEC, which is
accessible through
the SEC website.
Read more …
Delta Air Lines, Inc. (NYSE:DAL) COO W Gilbert West sold
15,000 shares of the firm’s stock in a transaction dated Friday, July 13th. The
shares were sold at an average price of $50.47, for a total value of
$757,050.00. Following the completion of the transaction, the chief operating
officer now owns 104,447 shares of the company’s stock, valued at approximately
$5,271,440.09. The sale was disclosed in a document filed with the SEC, which
is available through
this link.
W Gilbert West also recently made the following trade(s):
On Wednesday, April 18th, W Gilbert West sold 17,250 shares
of Delta Air Lines stock. The shares were sold at an average price of $55.00,
for a total transaction of $948,750.00.
DAL stock traded down $0.10 during mid-day trading on
Monday, hitting $50.67. 8,603,100 shares of the company were exchanged,
compared to its average volume of 7,634,792. The company has a quick ratio of
0.33, a current ratio of 0.39 and a debt-to-equity ratio of 0.51. The company
has a market capitalization of $35.61 billion, a PE ratio of 10.28 and a beta
of 1.12. Delta Air Lines, Inc. has a 1-year low of $44.59 and a 1-year high of
$60.79.
Read more ...
Accenture Plc (NYSE:ACN) insider Ellyn Shook sold 4,375
shares of Accenture stock in a transaction that occurred on Monday, July 16th.
The stock was sold at an average price of $168.02, for a total value of
$735,087.50. Following the sale, the insider now directly owns 31,707 shares in
the company, valued at approximately $5,327,410.14. The sale was disclosed in a
document filed with the SEC, which is available at
this link. Shares of ACN stock
opened at $168.07 on Wednesday. The firm has a market capitalization of $113.10
billion, a P/E ratio of 28.44, a P/E/G ratio of 2.50 and a beta of 0.97.
Accenture Plc has a one year low of $125.48 and a one year high of $168.95.
Read more …
Pfizer Inc. (NYSE:PFE) CEO Ian C. Read sold 486,753 shares
of the stock in a transaction on Monday, July 16th. The shares were sold at an
average price of $37.36, for a total value of $18,185,092.08. Following the
sale, the chief executive officer now directly owns 1,145,693 shares in the
company, valued at approximately $42,803,090.48. The transaction was disclosed
in a document filed with the Securities & Exchange Commission, which can be
accessed through
this hyperlink. Shares of NYSE:PFE
opened at $37.65 on Wednesday. The company has a current ratio of 1.27, a quick
ratio of 0.98 and a debt-to-equity ratio of 0.45. Pfizer Inc. has a 12-month
low of $32.32 and a 12-month high of $39.43. The stock has a market
capitalization of $223.41 billion, a price-to-earnings ratio of 14.21, a
price-to-earnings-growth ratio of 1.86 and a beta of 0.93.
Read more …